betamethasone valerate

Generic: betamethasone valerate

Labeler: padagis israel pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name betamethasone valerate
Generic Name betamethasone valerate
Labeler padagis israel pharmaceuticals ltd
Dosage Form AEROSOL, FOAM
Routes
TOPICAL
Active Ingredients

betamethasone valerate 1.2 mg/g

Manufacturer
Padagis Israel Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 45802-053
Product ID 45802-053_af10e709-e348-420b-aa9b-154c15cc5df3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078337
Listing Expiration 2026-12-31
Marketing Start 2013-01-15

Pharmacologic Class

Classes
corticosteroid hormone receptor agonists [moa] corticosteroid [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 45802053
Hyphenated Format 45802-053

Supplemental Identifiers

RxCUI
1244634
UNII
9IFA5XM7R2

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name betamethasone valerate (source: ndc)
Generic Name betamethasone valerate (source: ndc)
Application Number ANDA078337 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 1.2 mg/g
source: ndc
Packaging
  • 1 CAN in 1 CARTON (45802-053-01) / 50 g in 1 CAN
  • 1 CAN in 1 CARTON (45802-053-02) / 100 g in 1 CAN
source: ndc

Packages (2)

45802-053-01 1 CAN in 1 CARTON (45802-053-01) / 50 g in 1 CAN 45802-053-02 1 CAN in 1 CARTON (45802-053-02) / 100 g in 1 CAN

Ingredients (1)

betamethasone valerate (1.2 mg/g)

Linked Drug Pages (1)

Betamethasone Valerate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "af10e709-e348-420b-aa9b-154c15cc5df3", "openfda": {"unii": ["9IFA5XM7R2"], "rxcui": ["1244634"], "spl_set_id": ["dc5dfd3e-7762-40c8-880e-c7db80d87749"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CAN in 1 CARTON (45802-053-01)  / 50 g in 1 CAN", "package_ndc": "45802-053-01", "marketing_start_date": "20130115"}, {"sample": false, "description": "1 CAN in 1 CARTON (45802-053-02)  / 100 g in 1 CAN", "package_ndc": "45802-053-02", "marketing_start_date": "20130115"}], "brand_name": "Betamethasone Valerate", "product_id": "45802-053_af10e709-e348-420b-aa9b-154c15cc5df3", "dosage_form": "AEROSOL, FOAM", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "45802-053", "generic_name": "Betamethasone Valerate", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Betamethasone Valerate", "active_ingredients": [{"name": "BETAMETHASONE VALERATE", "strength": "1.2 mg/g"}], "application_number": "ANDA078337", "marketing_category": "ANDA", "marketing_start_date": "20130115", "listing_expiration_date": "20261231"}